1 company and 1 research report found for "Alimera Sciences"
No sector reports have been found.
Net revenue increased 89% to $3.9m in Q115 as in late February; Alimera
began US sales of its lead product, Iluvien. The intraocular steroid implant
Forgotten your login?
Registered office: Edison Investment Research Limited, 280 High Holborn, London, WC1V 7EE UK. Company no. 4794244. VAT no. 815041270
© 2017 All rights reserved. Edison Investment Research is authorised and regulated by the Financial Conduct Authority.
This site requires cookies in order to give you the best user experience.
Find out more